G8887
Glucokinase from Bacillus stearothermophilus
lyophilized powder, ≥250 units/mg protein
Synonym(s):
ATP:D-glucose-6-phosphotransferase
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
CAS Number:
MDL number:
UNSPSC Code:
12352204
Recommended Products
biological source
Bacillus sp. (B. stearothermophilus)
Quality Level
form
lyophilized powder
specific activity
≥250 units/mg protein
composition
Protein, ≥60% biuret
shipped in
dry ice
storage temp.
−20°C
Looking for similar products? Visit Product Comparison Guide
Unit Definition
One unit will phosphorylate 1.0 μmole of D-glucose to D-glucose 6-phosphate per min at pH 9.0 at 30 °C.
Physical form
Lyophilized powder containing Tris buffer salts
Storage Class
11 - Combustible Solids
wgk_germany
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Päivi J Miettinen et al.
Duodecim; laaketieteellinen aikakauskirja, 128(19), 1989-1998 (2012-11-20)
MODY (Maturity-Onset Diabetes of the Young) is a group of monogenic disorders characterized by autosomally dominantly inherited diabetes or hyperglycemia typically detected during adolescence or young adulthood. Usually there is at least one person in the family having developed the
Response to Comment on: Chakera et al. Antenatal diagnosis of fetal genotype determines if maternal hyperglycemia due to a glucokinase mutation requires treatment. Diabetes Care 2012;35:1832-1834.
Ali J Chakera et al.
Diabetes care, 36(1), e15-e15 (2012-12-25)
Comment on: Chakera et al. Antenatal diagnosis of fetal genotype determines if maternal hyperglycemia due to a glucokinase mutation requires treatment. Diabetes Care 2012;35:1832-1834.
Edoardo Tartaglia et al.
Diabetes care, 36(1), e14-e14 (2012-12-25)
Matthew D Blankschien et al.
ACS nano, 7(1), 654-663 (2012-12-15)
The use of plasmonic nanoparticle complexes for biomedical applications such as imaging, gene therapy, and cancer treatment is a rapidly emerging field expected to significantly improve conventional medical practices. In contrast, the use of these types of nanoparticles to noninvasively
David Callejas et al.
Diabetes, 62(5), 1718-1729 (2013-02-05)
Diabetes is associated with severe secondary complications, largely caused by poor glycemic control. Treatment with exogenous insulin fails to prevent these complications completely, leading to significant morbidity and mortality. We previously demonstrated that it is possible to generate a "glucose
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service
